Tissue Restoration – Regbiomed http://regbiomed.com/ Thu, 28 Jul 2022 16:16:11 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.3 https://regbiomed.com/wp-content/uploads/2021/09/icon-150x150.png Tissue Restoration – Regbiomed http://regbiomed.com/ 32 32 A recent study confirms the medical findings on the effectiveness of https://regbiomed.com/a-recent-study-confirms-the-medical-findings-on-the-effectiveness-of/ Thu, 28 Jul 2022 16:16:11 +0000 https://regbiomed.com/a-recent-study-confirms-the-medical-findings-on-the-effectiveness-of/ TRUMBULL, Connecticut, July 28 12, 2022 (GLOBE NEWSWIRE) — Sustained Acoustic Medicine (SAM) delivered by Zetroz Systems’ sam® device is effective in healing soft tissue injuries, restoring function in patients and help them return to work or other normal daily activities. The study, published in the journal BMC Sports Science, Medicine and Rehabilitationis a systematic […]]]>

TRUMBULL, Connecticut, July 28 12, 2022 (GLOBE NEWSWIRE) — Sustained Acoustic Medicine (SAM) delivered by Zetroz Systems’ sam® device is effective in healing soft tissue injuries, restoring function in patients and help them return to work or other normal daily activities.

The study, published in the journal BMC Sports Science, Medicine and Rehabilitationis a systematic review and meta-analysis to analyze the effects of SAM treatment on musculoskeletal injuries, including diathermy (tissue heating), functional outcomes (strength and range of motion), quality of life, pain reduction and the safety profile of the intervention.

The authors reviewed 13 previously published studies involving 372 patients. “Sustained Acoustic Medicine treatment results in warming and tissue recovery, improving patient function and reducing pain,” the authors found. “When patients have failed to respond to physical therapy, Sustained Acoustic Medicine has proven to be a useful adjunct to facilitate recovery and return to work. As a non-invasive, non-narcotic treatment option with an excellent profile safety, sustained acoustic medicine can be considered a good therapeutic option for practitioners.”

The study also concluded that sam® performed the following functions:

  1. Accelerates return to function and performance: When patients did not respond to traditional therapies (RICE), 87% experienced improved function and quality of life, and 55% were able to return to their activities immediately after the treatment.
  2. Provides a safe and strong diathermic effect. Targeted patient tissues experienced a significant change in therapeutic heat, an increase of 4°C to 12°C, while maintaining a safe temperature on the skin.
  3. Lowers lactic acid and improves muscle and joint performance: Patients have seen a 20% reduction in blood lactate, an improvement in joint function of 27-87%, and an increase in power, work and torque.
  4. HEALS WHILE REDUCING PAIN: Long-duration, low-intensity ultrasound like the sam® treatment increases vasodilation (blood flow and oxygenation), which expands the collagen fiber matrix, accelerating healing and increasing the integrity of the joints. injured soft tissue, significantly reducing patient pain.
  5. Easy to integrate into the patient’s home self-care regimen: 95% of patients were able to apply and perform the sam® treatment, and 93% of patients found sam® to be very easy to use.

“This new study confirms what we know from years of research and development and patient experience,” said George K. Lewis, Ph.D., and CEO of ZetrOZ Systems. “We hope to see sustained acoustic medicine widely adopted by physicians and healthcare providers to help even more people with soft tissue healing, reduce pain, and return them to normal daily activities even faster.”

The researchers’ summary agrees, suggesting that medical practitioners are considering more widespread adoption of SAM. “The data presented in these clinical studies show positive and significant benefits for patients,” they wrote. “Furthermore, a recent survey analysis of health economics and SAM practitioners supports the adoption of medical guidelines for SAM as a new mechanobiological treatment for patient care. SAM treatment, which is widely used in sports medicine, can be considered more broadly as a non-invasive, safe and effective treatment option for patients with musculoskeletal pain and soft tissue injuries.”

To learn more about ZetrOZ Systems and its innovative healthcare solutions, visit www.zetroz.com.

About ZetrOZ Systems

ZetrOZ Systems is an FDA cGMP and ISO 13585 medical technology company headquartered in the Southern Coastal region of Connecticut. The organization also has manufacturing facilities across the United States. ZetrOZ Systems produces UltrOZ®, sam®Sport and sam®Pro 2.0 to provide safe and effective treatment options for common conditions such as arthritis. Learn more at zetroz.com and samrecover.com.

Media Contact

Kayar nozzle
buse@newswire.com

Related images

Image 1: sam® 2.0 is available for home use to treat common soft tissue injuries

This content was posted through the press release distribution service on Newswire.com.

  • sam® 2.0 is available for home use to treat common soft tissue injuries

]]>
Precise Bio partners with Carl Zeiss for corneal transplants https://regbiomed.com/precise-bio-partners-with-carl-zeiss-for-corneal-transplants/ Tue, 26 Jul 2022 14:55:40 +0000 https://regbiomed.com/precise-bio-partners-with-carl-zeiss-for-corneal-transplants/ Carl Zeiss Meditec has partnered with regenerative medicine company Precise Bio to develop and commercialize its transplantable corneal tissue 4D printing technology. The products are intended for patients requiring a corneal transplant to restore vision. Under the terms of the agreement, Jena, Germany-based Carl Zeiss Meditec will invest in Precise Bio and fund the further […]]]>

Carl Zeiss Meditec has partnered with regenerative medicine company Precise Bio to develop and commercialize its transplantable corneal tissue 4D printing technology. The products are intended for patients requiring a corneal transplant to restore vision.

Under the terms of the agreement, Jena, Germany-based Carl Zeiss Meditec will invest in Precise Bio and fund the further development of Precise Bio’s two corneal transplant products. Carl Zeiss Meditec will retain worldwide marketing rights to these products under the agreement.

Financial terms were not disclosed.

Globally, only one cornea is available for 70 patients needing a transplant, according to Precise Bio. The technology developed by the company would offer a complete solution for corneal transplantation and alleviate the shortage of donated corneas.

Carl Zeiss Meditec, a leading medical technology company specializing in the diagnosis and treatment of eye disease, said the investment will complement its portfolio of refractive cataract and corneal workflow solutions. “The technology has the potential to advance treatment options for corneal diseases, as well as elective procedures, further optimizing patient care,” said Euan S. Thomson, PhD, president of ‘Ophthalmic Devices and Head of the Digital Business Unit at Carl Zeiss Meditec.

Precise Bio combines engineering, biomaterials, cell technology, bioengineering and 3D printing in a 4D bio-fabrication platform for transplantable organs and tissues. The proprietary technology enables tissue fabrication by printing cells in single-cell resolution with spatial precision, producing complex constructs with structural integrity and long-term cell viability, according to the company. Biofabrication technology could be reliably scaled up for clinical use and can produce large quantities in a reproducible, quality-controlled, and cost-effective process.

Image courtesy of Precise Bio
Precise Bio has developed a bio-manufacturing platform for the scalable production of corneal grafts.

Precise Bio’s ophthalmology pipeline consists of three products – both corneal transplants for diseases requiring endothelial keratoplasty and lenticule replacement, which are the subject of the collaboration with Carl Zeiss Meditec, and a retinal implant for degeneration age-related macular. All products performed well in animal models, according to Precise Bio. The ophthalmology products cater to global markets exceeding $10 billion annually, the company said.

Precise Bio was founded in 2016 by Professor Anthony Atala, MD, director of the Wake Forest Institute of Regenerative Medicine (WFIRM), Professor Shay Soker, PhD, also of WFIRM, and Aryeh Batt, who developed the printing technology company laser. The company has facilities in Winston Salem, North Carolina, and Modi’in, Israel.

]]>
it is now possible to regain virginity https://regbiomed.com/it-is-now-possible-to-regain-virginity/ Sun, 24 Jul 2022 18:47:22 +0000 https://regbiomed.com/it-is-now-possible-to-regain-virginity/ Due to the openness of society, people live in a life relationship without marriage, Due to which girls lose their virginity before marriage, Besides playing, Dancing and using sanitary napkins like tampons also rupture the membrane of virginity, In such a situation, it can be recovered with hymenoplasty (hymen restoration surgery) at nominal cost and […]]]>

Due to the openness of society, people live in a life relationship without marriage, Due to which girls lose their virginity before marriage, Besides playing, Dancing and using sanitary napkins like tampons also rupture the membrane of virginity, In such a situation, it can be recovered with hymenoplasty (hymen restoration surgery) at nominal cost and in a very short time. Previously, its trend was in western countries, but now hymen restoration surgery is becoming common in our country, especially in cities.

A few years ago, you wouldn’t have thought that virginity (virginity, virginity) could return, but thanks to advances in medical science, today women can achieve virginity when and as many times as they want. wish. Such a special medical procedure is possible with hymenoplasty. Due to the openness of society, people live in a non-marital life relationship, due to which girls lose their virginity before marriage, in addition to playing, dancing and using sanitary napkins as pads. tampons also rupture the virginity membrane, in such a case hymenoplasty It can be recovered with (hymen restoration surgery) that too at nominal cost and in a very short time. Previously, its trend was in western countries, but now hymen restoration surgery is becoming common in our country, especially in cities.

Divorcees, widows, living and women who have lost their virginity due to any reason take the help of hymenoplasty to prove themselves virgins before the husband in marriage. Along with this, vaginoplasty for vaginal tightening and bulbospongioplasty improve lip flare and rejuvenate the genitals. In the changing social environment, married women also adopt them who want to fully enjoy sex life.

What is the reality ?

The hymen or virgin membrane is mucous tissue that partially blocks the passage to the vagina. The size of the hymen varies from woman to woman, some with thin elastic and others with thicker, less stretchy tissue. Some also have a different hymen structure, such as the imperfect hymen, which keeps the vagina completely closed, they must be opened surgically during menstruation. After adolescence, as age advances, the hymenal tissue weakens and becomes so thin that it is torn even by activities such as cleaning, physical exercise, or running in sports.

misconceptions about virginity

There are many cultures in many countries around the world that consider it a symbol of virginity, honor or purity. Research has shown that the hymen is not necessarily ruptured due to sex or play, there have been cases in which weakness caused by serious illness has ruptured the hymen. In some cases, there is no bleeding due to rupture of the hymen during the first sexual intercourse, this is due to the special structure of the tissue of the hymen, due to which it becomes flexible during sexual intercourse and spreads so much that there is no risk of it breaking. This is the reason why many women do not experience pain during the first sexual intercourse, but lack of excitement during intercourse, dryness or lack of lubrication in the vagina and forced penetration increase the risk of bleeding with pain.

In many cultures, a woman’s virginity is detected by bloodstains on the sheet at first intercourse after marriage, but bleeding at first intercourse is not necessary. Ideal intercourse means that when the woman is mentally ready for sex, during easy penetration, the hymen tissue does not burst and there is no bleeding, even if it does, in the form of few drops.

Virginity still pregnant: There have been many cases in which the hymen tissue has not been torn but the woman has become pregnant. When the examination was done, it was found that there are naturally one or two holes in the hymen, if the man’s ejaculation occurs near the vaginal entrance, then the sperm cells break through a way through these holes and the result is visible in the form of pregnancy.

Why and who needs hymenoplasty?

Women adopt hymenoplasty for two reasons, the first reason is the belief based on religious and cultural beliefs that the girl must be a virgin before marriage, otherwise it is a matter of embarrassment for the girl and her family. These beliefs are so strong that divorce happens when the hymen is broken, which is why most girls take special care that the hymen is not broken before marriage. The second reason is to regain the pleasure of celibacy, many women, regardless of social beliefs, undergo hymenoplasty to become a virgin again on the day of marriage with the consent of their husband. A trend has also started that many married men ask their wives for hymenoplasty to make their wedding anniversary memorable so that her virginity will be reborn and they can enjoy celibacy again. As in western countries, hymenoplasty is legal in our country and every woman has the right to have sexual pleasure through vaginal rejuvenation, that’s why there is a growing trend of hymenoplasty along with vaginoplasty and bulbospongioplasty to improve lip thrust. He goes.

Nowadays, sanitary napkins and menstrual cups like tampons are a major cause of hymen breakdown before marriage, so before suspecting a woman’s virginity, know that she does not use them. Cycling, swimming, gym and horse riding also break the membrane of virginity.

Hymenoplasty and vaginal rejuvenation procedure

The hymen, which is usually torn during intercourse, plastic surgeons restore it to hymenoplasty as it was before intercourse. In some cases, vaginoplasty is necessary to cause the vagina to be tightened so that the woman feels physically completely single and the same feeling returns to her husband or partner.

The hymenoplasty procedure is performed by placing the patient in a lithotomy position under local anesthesia, connecting the torn remnants of the hymen by tightening the inner mucosa through an incision in the vestibular mucosa behind the vaginal wall, present on both sides. The dissected bulbospongiosus muscle is reattached, then the tissue is sutured from the outer edge to the inner end by placing tissue over the mucosa. It does not require any dressings, after the operation the patient should go home and apply only healing ointment. Analgesics are given to relieve pain and antibiotics to prevent infection. It takes seven to eight days to heal, during which sometimes pain and light bleeding may be felt. Usually the patient feels comfortable after a week.

This procedure is completely painless, but many patients take sleeping pills to avoid pain at all. It has a success rate of up to 98% and the whole procedure takes 15-30 minutes. Its cost in our country ranges from 25 to 35 thousand.

Who can do hymenoplasty?

For this, the gynecologist and the plastic surgeon are suitable, but if the plastic surgeon performs this work under the supervision of a gynecologist, better results are obtained. An OB-GYN with experience in cosmetic gynecological surgery in medical science is considered the safest option for this. Remember that a woman must be at least 18 years old to undergo hymenoplasty.

These precautions are necessary

Most complications are caused by not following doctor’s advice after surgery and they are more for those who are in a rush to have sex, so don’t have sex for at least 6 weeks. Having sex after hymenoplasty causes bleeding like the first time. Do not use tampons as sanitary napkins. For at least two weeks after surgery, wear tight underwear and avoid activities such as walking, climbing stairs, and lifting weights.

Change your mind, everything will change

Experts say that loose muscles due to sexual intercourse and childbirth worsen the shape of the vagina, in such cases these procedures are able to rejuvenate the vagina, but it is not fair to say that virginity will return, because those who believe in things like virginity They must understand that by making a hymen in the vagina, virginity does not come, sexual activities have more effect on the mind than on the body, whoever has had sexual intercourse, her virginity cannot be restored by any surgery, only sports, exercise, such as horseback riding By redoing the hymen torn by activities, unmarried girls can be made physically celibate by the mind.

In any conservative patriarchal country, preserving virginity until marriage is always seen as a necessity and an added attraction, because of this, many women are lining up for that cosmetic hymen restoration surgery that will help their future lives. in-laws. She will maintain this pristine state before her husbands and husbands. This procedure gives women a good start in married life by giving them the opportunity to become physically virgins again, bypassing gender discrimination.

]]>
3D Printing Medical Devices Market Size, Trends, Industry Share, Growth by 2022-2028: 3D Systems Corporations, Cyfuse Medical KK, Stratasys Ltd., EOS GmbHConcept https://regbiomed.com/3d-printing-medical-devices-market-size-trends-industry-share-growth-by-2022-2028-3d-systems-corporations-cyfuse-medical-kk-stratasys-ltd-eos-gmbhconcept/ Fri, 22 Jul 2022 23:19:32 +0000 https://regbiomed.com/3d-printing-medical-devices-market-size-trends-industry-share-growth-by-2022-2028-3d-systems-corporations-cyfuse-medical-kk-stratasys-ltd-eos-gmbhconcept/ SWOT Analysis of 3D Printing Medical Devices Market by Key Players | 3T RPD Ltd., Prodways Group, Oxford Performance Materials, Inc., SLM Solutions Group AG This press release was originally issued by SBWire Pune, Maharashtra — (SBWIRE) – 07/22/2022 – In the healthcare industry, 3D printing, also known as additive manufacturing, is used to produce […]]]>

SWOT Analysis of 3D Printing Medical Devices Market by Key Players | 3T RPD Ltd., Prodways Group, Oxford Performance Materials, Inc., SLM Solutions Group AG

This press release was originally issued by SBWire

Pune, Maharashtra — (SBWIRE) – 07/22/2022 – In the healthcare industry, 3D printing, also known as additive manufacturing, is used to produce a variety of medical items, including orthopedic and cranial implants, instruments surgical, dental restorations, including crowns, and external prostheses. By creating medical equipment specifically tailored to individual needs, 3D printing technology is growing in response to the growing need for individualized medical care. Medical device manufacturers have been driven to use 3D printing to shorten the manufacturing lifecycle and remove the conventional prototyping process due to ever-increasing cost pressures and their great need to develop new products. new products.
According to SNS Insider’s market research report, the 3D printing medical devices market is expected to exceed USD 8.4 billion by 2028 growing at a CAGR of 7.8% during the forecast period 2022- 2028.

Book your free sample report @ https://www.snsinsider.com/sample-request/1185?utm_source=KailasRW

Drivers, constraints, opportunities and challenges
The global 3D printing medical device market has witnessed dynamic growth in recent years owing to accelerating technological development, increasing R&D expenditures, and accelerated customer expansion. Additionally, it is anticipated that the use of 3D printing technology in the healthcare industry will enable efficient preoperative planning, improved surgical technique, better patient outcomes, and a viable substitute for animal testing. . Additionally, the expansion of direct digital manufacturing and the expiration of major patents in the 3D printing industry will help drive the market expansion in the coming years.
The high cost of sophisticated 3D printers, the lack of well-defined regulatory frameworks and refund policies, copyright and patent difficulties in 3D printing patented products, and other factors are expected to hold back market expansion.

Impact of the COVID-19 pandemic
The sudden increase in COVID-19 cases has made it urgent to increase testing and protect healthcare workers. Nasopharyngeal swabs, which are used to collect nasal epithelial lining for diagnostic and testing purposes, were in high demand due to the COVID-19 outbreak. Due to the unpredictable demand for these swabs, researchers and many companies have turned to 3D printing to ensure an adequate supply of these tools.

Market segmentation
By technology
1. Fusion of the laser beam
2. Electron beam fusion
3. Light curing
4. Droplet deposition
5.Three-dimensional printing/Binder jetting
6. Other technologies

By component
1.Materials
2.Equipment
3.Services and software

By request
1. Standard prostheses and implants
2. Personalized prostheses and implants
3. Portable medical devices
4.Surgical instruments
5. Tissue engineered products
6. Surgical guides
7. Hearing aids
8. Other applications

Per end user
1. Hospitals and surgical centers
2.University institutions and research laboratories
3. Dental and orthopedic clinics
4. Clinical research organizations
5. Pharmaceutical, biotechnology and medical device companies

The 3D printing medical device market is expected to be driven by the light curing segment in terms of technology. In the process of light-curing, a 3D printing technique, drops of liquid plastic are subjected to a laser beam of UV light, causing the light to solidify the liquid.
The services and software segment recorded a notable percentage of market revenue, broken down by component. This increase is linked to an increase in the adoption of software that encourages the use of additive manufacturing in the medical technology industry.
The hospital and surgical center segment is expected to dominate the 3D printing medical devices market on the basis of end-user. The expansion of the segment is mainly fueled by the growing use of 3Printing in healthcare facilities.

Regional analysis
The 3D printing system market is expected to witness significant growth in the Asia-Pacific and LAMEA regions owing to the rise of new businesses and rising public awareness. The development of the 3D printing medical devices market in the Asia-Pacific region is fueled by factors such as increasing government funding to improve 3D printing applications in the healthcare sector, establishment of facilities research and training and awareness of 3D printing through conferences and events. Due to the growing demand for 3D printed medical equipment and growing awareness of these products in the region, North America is expected to experience rapid growth.

Competitive Landscape Insights
Some of the major market players operating in the 3D printing. medical device market.

Buy this exclusive report @ https://www.snsinsider.com/checkout/1185?utm_source=KailasRW

Contents
1. Introduction
1.1 Market definition
1.2 Scope
1.3 Research hypotheses

2. Research methodology

3. Market dynamics
3.1 Drivers
3.2 Constraints
3.3 Opportunities
3.4 Challenges

4. Impact analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of Ukrainian articles

5. Value chain analysis

6. Porter’s 5 forces model

7. PEST Analysis

8. 3D Printing Medical Devices Market Segmentation, By Technology
8.1 Laser beam fusion
8.2 Electron beam fusion
8.3 Light-curing
8.4 Droplet deposition
8.5 Three-dimensional printing/binder jetting
8.6 Other technologies

9. 3D Printing Medical Devices Market Segmentation, By Component
9.1 Materials
9.2 Equipment
9.3 Services & Software

10. 3D Printing Medical Devices Market Segmentation, By Application
10.1 Standard prostheses and implants
10.2 Personalized prostheses and implants
10.3 Portable medical devices
10.4 Surgical instruments
10.5 Tissue-engineered products
10.6 Surgical guides
10.7 Hearing aids
10.8 Other applications

11. 3D Printing Medical Devices Market Segmentation, By End User
11.1 Hospitals and surgical centers
11.2 Academic Institutions and Research Laboratories
11.3 Dental and orthopedic clinics
11.4 Clinical research organizations
11.5 Pharmaceutical, biotechnology and medical device companies

12. Regional analysis
12.1 Presentation
12.2 North America
12.2.1 United States
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 United Kingdom
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 Netherlands
12.3.7 Rest of Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.2 South Korea
12.4.3 China
12.4.4 India
12.4.5 Australia
12.4.6 Rest of Asia-Pacific
12.5 The Middle East and Africa
12.5.1 Israel
12.5.2 WATER
12.5.3 South Africa
12.5.4 Rest
12.6 Latin America
12.6.1 Brazil
12.6.2 Argentina
12.6.3 Rest of Latin America

13. Business Profiles
13.1 3D system companies
13.1.1 Financial
13.1.2 Products/services offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Cyfuse Medical KK
13.3 Stratasys Ltd.
13.4 EOS GmbH Concept
13.5 3T RPD Ltd.
13.6 Prodways Group
13.7 Oxford Performance Materials, Inc.
13.8 SLM Solutions Group SA
13.9 Arcam AB
13.10 EnvisionTEC
13.11 Organovo Holdings, Inc.
13.12 Bio3D Technologies
13.13 Renishaw plc
13.14 Materialize NV
13.15 Laser GmbH

14. Competitive Landscape
14.1 Competitive benchmark
14.2 Market Share Analysis
14.3 Recent Developments

15. Conclusion

Contact us:
Akash Anand
Head of business development and strategy
[email protected]
IND: +91-7798602273
USA: +1-415-230-0044

For more information on this press release, visit: http://www.sbwire.com/press-releases/3d-printing-medical-devices-market-size-trends-industry-share-growth-by-2022-2028-3d-systems-corporations-cyfuse-medical- kk-stratasys-ltd-eos-gmbhconcept-1361154.htm

]]>
Zirconia materials provide solutions to the problem of missing teeth https://regbiomed.com/zirconia-materials-provide-solutions-to-the-problem-of-missing-teeth/ Wed, 20 Jul 2022 21:27:33 +0000 https://regbiomed.com/zirconia-materials-provide-solutions-to-the-problem-of-missing-teeth/ I. Main causes of missing teeth The largest number of reported cases of tooth loss worldwide are due to periodontal disease or gum disease. The disease is caused by dental plaque and the body’s defense mechanism acts against the bacteria by releasing substances that cause inflammation of the gums. The first symptoms of the disease […]]]>

I. Main causes of missing teeth

The largest number of reported cases of tooth loss worldwide are due to periodontal disease or gum disease. The disease is caused by dental plaque and the body’s defense mechanism acts against the bacteria by releasing substances that cause inflammation of the gums. The first symptoms of the disease are bleeding and swollen gums. As the infection spreads, it reaches the bone under the tooth and destroys the supporting system, causing the tooth to fall out of the socket.

A person’s genetics can also lead to missing teeth in the form of an inherited condition known as ectodermal dysplasia. In such cases, the wisdom teeth may be missing or the lateral incisors may not appear at all. This can lead to chewing and biting problems and lack of nutrition. It can even destroy the structure of the jawbone and create large gaps between the teeth or lead to crowding which can be treated by an orthodontic expert.

Cavities left untreated for a long time or poor dental care can also lead to tooth loss. Certain other diseases can cause the problem, such as type 2 diabetes and high blood pressure, which can make your gum disease worse and lead to tooth loss. In addition to this, an injury or an accident can be another cause of missing teeth.

II. The dangers of missing teeth

1. Functional risks

1) The integrity of the teeth is destroyed: After a tooth is missing, if it is not repaired for a long time, the adjacent teeth bow due to the loss of support and restraint, which can easily lead to bite dysfunction.

2) Alveolar bone atrophy: after the loss of teeth, the physiological stimulation of the alveolar bone by the normal biting force no longer exists, and the alveolar bone will have different degrees of disuse atrophy, and it will restore the prostheses dental and will maintain the oral and the maxillofacial. area at a later stage. balance and stability bring great difficulties.

3) Decreased masticatory function: After tooth loss, a series of changes occurred in the remaining teeth, leading to changes in the original good bite relationship. Due to the corresponding reduction in the effective functional area between the remaining teeth, the efficiency of chewing is reduced.

4) Food impaction: normal teeth are arranged very closely. After moving the adjacent teeth, there will be gaps between the teeth. It is easy for food to be impacted in the spaces between the teeth, causing bad breath, tooth decay, periodontal disease, etc.

5) Loss of teeth: Since the teeth to the left and right of the missing tooth cannot get the supporting pressure they normally have, they can become asymmetrical in the gums, gradually loosening the teeth and causing the teeth to fall out of some teeth.

2. Cosmetic risks

1) Temporomandibular joint disease: Long-term unilateral missing teeth will also develop the habit of unilateral chewing, resulting in facial asymmetry and joint symptoms.

2) Affect the shape of the face: Once all the teeth are missing, the person as a whole will look much older than their peers.

3) Affecting social interaction: Tooth loss can make people’s pronunciation non-standard and affect communication activities.

III. Using Zirconia Materials to Fix Missing Teeth

Considering the dangers of missing teeth, whether it is one missing tooth or multiple missing teeth, it is best to fix it as soon as possible within three to six months.

So how to fix missing teeth? The answer is to use zirconia materials to repair missing teeth. We can solve this problem with zirconia dental implants.

Ⅳ. Options for replacing missing teeth

1. Zirconia dental implants

Dental implants are an option when you need to replace a single tooth or when you are missing multiple teeth in different areas of your mouth.

This treatment involves surgically fitting a titanium post or frame into your upper or lower jawbone. A zirconia tooth is then mounted on the implant, allowing the tooth to stay in place.

Basically, a zirconia dental implant provides a permanent base for a replacement tooth.

2. Zirconia fixed dental bridge

If you don’t want a dental implant, see if you are a candidate for a fixed dental bridge. This zirconia replacement option can be effective if you are missing one or more teeth in the same area.

A zirconia fixed bridge basically fills a gap caused by a missing tooth using a denture or an artificial tooth. The prosthesis is attached to the adjacent teeth and then cemented in place using dental cement.

Ⅴ. Zirconia removable partial dentures

Your dentist may suggest full zirconia dentures if you need to replace all of your teeth. But if you only need to replace some of your teeth, you might be a candidate for a removable zirconia partial denture.

This brace consists of replacement teeth attached to a natural looking pink base.

The natural teeth stabilize and hold the removable plastic base in place, although some dentures have a clasp that adjoins the natural teeth.

The base is designed to match the color of your gums and the teeth to match the color of your natural teeth. These dentures may be an option if you need to replace several teeth in one part of your mouth.

Ⅵ. The Benefits of Using Blommden Zirconia Materials

1. Aesthetic

The all-ceramic denture restoration looks realistic and beautiful, and the color is similar to natural teeth. The most important thing is that the all-ceramic denture has good translucency and refraction, and there will be no black lines on the tooth neck, so that the tooth neck can also achieve a good effect aesthetics, which is impossible to catch with an ordinary porcelain prosthesis.

2. Biocompatibility

Zirconia for medical and dental applications has excellent biosafety properties. Over the years, a large number of experimental and clinical cases have proven that zirconia does not cause any toxic damage to bone cells and soft tissues, and no cases of allergic reaction have been reported.

3. High strength and density

1) Zirconia ceramics are high flexural strength yttrium stabilized zirconia ceramics. At present, the strength of materials registered in China has reached 900 MPa, while the national standard for dental materials is 100 MPa.

2) Compared to other all-ceramic restorative materials, the strength of Zirconia material allows doctors to achieve extremely high strength without excessive grinding of the patient’s real teeth. Among them, Vita all-ceramic plus yttrium and stabilized zirconia oxide plus is also known as ceramic steel.

4. Accuracy

Production is carried out using computer-aided design, laser scanning and computer-programmed grinding. It guarantees the precision of the molded coping and excellent sealing of the edges, allowing the porcelain tooth to adapt perfectly to the abutment in the patient’s mouth.

4. Low radioactivity

State Food and Drug Administration standards have strict standards for all ceramic materials on the market and can only be used as medical materials after meeting the requirements of radiological experiments. Not only are there requirements for zirconia, but also for decorative porcelain, alumina, glass ceramics, etc. Experiments show that the radioactivity of pure zirconia powder is not only lower than that of glass ceramics, but also lower than that of human bone tissue.

If you want to know more about zirconia materials, please contact them immediately:

https://www.bloomden.com

Media Contact
Company Name: Bloomden Bioceramics Co., Ltd
Contact person: Leon
E-mail: Send an email
Call: +86-13135117836
Country: China
Website: https://www.bloomden.com

]]>
Excerpt from reviews: MCP https://regbiomed.com/excerpt-from-reviews-mcp/ Tue, 19 Jul 2022 07:25:38 +0000 https://regbiomed.com/excerpt-from-reviews-mcp/ The long term effects of limited oxygen in the womb. How Alzheimer’s disease alters global proteome turnover. Spatial proteomics offers insight into the mechanisms of HIV-1. Discover the articles on these subjects recently published in the journal Molecular and Cellular Proteomics. Limited oxygen in the womb has long term effects Hypoxia is the state of […]]]>

The long term effects of limited oxygen in the womb. How Alzheimer’s disease alters global proteome turnover. Spatial proteomics offers insight into the mechanisms of HIV-1. Discover the articles on these subjects recently published in the journal Molecular and Cellular Proteomics.

Limited oxygen in the womb has long term effects

Hypoxia is the state of insufficient oxygen in the tissues, and chronic hypoxia refers to a long-lasting low oxygen content in the blood. Hypoxia during pregnancy affects more than 2% of the world’s population, especially people living at high altitudes. It disrupts the development of the embryo, which increases the risk of multiple chronic diseases, including diabetes and chronic cardiovascular and kidney disease, in adulthood.

In a recent paper in the review Molecular and Cellular Proteomics, Stefan Rudloff from the University of Bern, Andrea Bileck from the University of Vienna and a team of researchers describe the effects of chronic hypoxia on the kidneys of mouse fetuses. By comparing the proteomes of kidneys under hypoxia and kidneys under normal oxygen conditions, they determined that hypoxia causes significant dysregulation of proteins related to kidney development, metabolic adaptation and premature aging. .

Nephrons are the structural and functional unit of the kidney. Under hypoxic conditions, fewer nephrons form, increasing the risk of kidney dysfunction and kidney failure in adulthood. Additionally, chronic hypoxia causes neutrophils to accumulate at sites of nephron formation, causing the tissue damage and DNA oxidation seen in hypoxic fetal kidneys.

In response to a lack of oxygen, cells attempt to adjust metabolic pathways from oxygen-dependent oxidative phosphorylation to oxygen-independent glycolysis to extract energy from sugars. The researchers observed elevated levels of the 10 enzymes involved in glycolysis in hypoxic fetal kidneys. They discovered that the Klotho protein, which functions both as a intracellular anti-inflammatory and one systemic anti-aging factor, was already down-regulated in fetal kidneys.

The authors concluded that the steps taken by fetal cells to survive hypoxia, instead of developing normally, may predispose tissues to more rapid aging in adulthood. Researchers can use the characteristic biomarkers of this accelerated aging to detect and target human diseases caused by chronic hypoxia.

Does Alzheimer’s disease affect global proteome renewal?

The rate of protein turnover in cells depends on the rate of protein synthesis and breakdown. Depending on the tissue, proteins can have different turnover rates. For example, proteins in mammalian brains have a higher rate (minutes to days) than skeletal muscle proteins (usually weeks). Researchers believe that imbalances in protein turnover are a primary factor in common neurodegenerative diseases such as Alzheimer’s disease. Due to these imbalances, some neuronal proteins misfold and form aggregates that cannot be restored to their native form. Scientists do not yet know whether neurodegenerative diseases affect proteome turnover beyond the brain.

In a recent article in the review Molecular and Cellular Proteomics, Byron Andrews of the Medical Research Council Laboratory of Molecular Biology in the UK and a team of researchers describe their study of global proteome turnover at different stages of Alzheimer’s disease and amyotrophic lateral sclerosis, or ALS, in three models of transgenic mice. Healthy mice were used as a control for the experiment.

The researchers’ results showed an increase in overall average protein turnover at a later stage of the disease in all three mouse models. This suggests that protein repair mechanisms are increasingly active as the disease progresses. The change in turnover was limited to proteins in the forebrain, the region affected by Alzheimer’s disease. Serum and liver protein turnover were not affected. In contrast to disease models, overall proteome turnover in healthy mice showed a consistent decrease with aging. The authors attributed this to the slowing of protein degradation by autophagy with aging.

Spatial proteomics offers insight into HIV-1 mechanisms

Cells are made up of organelles, compartments that perform specific tasks. Organelles need specific proteins to function, and the location of a protein in a cell provides valuable information about its function. This localization of proteins is a strictly regulated process.

In order to escape detection by the cellular immune system and continue to multiply, viruses disrupt protein localization, leading to protein inactivation and cellular dysfunction. Spatial proteomics provides information on the localization of proteins in organelles and is therefore a promising tool to understand the mechanism of disease progression at the subcellular level. The usual spatial proteomic analysis depends on the proteome of the reference organelle; therefore, it cannot be used if the proteins are translocated to different organelles. Researchers have not yet established which is the best method to study cellular disruptions caused by viral infection.

In a recent article published in the journal Molecular and Cellular Proteomics, Aaron L. Oom of the University of California, San Diego, and a team of researchers describe the use of machine learning models to analyze protein localization in various human T cell organelles containing an inducible HIV-1 genome . When these cells grew in the presence of an inducer (doxycycline in this case), the viral genome was also expressed and HIV infection disrupted the subcellular localization of proteins.

The researchers analyzed the host cell’s spatial proteomics data using three machine learning models. The performance of these models is organelle-dependent, which means that for a particular organelle, one model performs better than the others. This result suggests that researchers should choose an appropriate machine learning model to analyze spatial proteomics data of a specific organelle for the study of HIV-1 infection mechanism. This work serves as a reference for the study of viral infections as well as additional mutants of the HIV-1 genome.

]]>
Morgan Stanley lowers NuVasive (NASDAQ:NUVA) price target to $54.00 https://regbiomed.com/morgan-stanley-lowers-nuvasive-nasdaqnuva-price-target-to-54-00/ Sun, 17 Jul 2022 08:08:05 +0000 https://regbiomed.com/morgan-stanley-lowers-nuvasive-nasdaqnuva-price-target-to-54-00/ NuVasive (NASDAQ: NUVA – Get a rating) saw its price target lowered by Morgan Stanley equity researchers from $62.00 to $54.00 in a report on Friday, Target Stock Advisor reports. The brokerage currently has an “equal weight” rating on shares of the medical device company. Morgan Stanley’s price target indicates a potential upside of 8.52% […]]]>

NuVasive (NASDAQ: NUVAGet a rating) saw its price target lowered by Morgan Stanley equity researchers from $62.00 to $54.00 in a report on Friday, Target Stock Advisor reports. The brokerage currently has an “equal weight” rating on shares of the medical device company. Morgan Stanley’s price target indicates a potential upside of 8.52% from the current stock price.

Several other stock analysts have also released reports on the stock. Needham & Company LLC reiterated a “buy” rating and set a target price of $64.00 on NuVasive shares in a Thursday, March 24 report. StockNews.com began covering NuVasive shares in a report on Thursday, March 31. They issued a “holding” rating for the company. Truist Financial began covering NuVasive shares in a report on Wednesday, April 13. They issued a “buy” rating and a price target of $65.00 for the company. Finally, Wells Fargo & Company began covering NuVasive shares in a Monday, March 28, report. They issued an “overweight” rating and a price target of $58.00 for the company. One research analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned the company’s stock a buy rating. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $62.80.

NuVasive Trading up 2.9%

Action NuVasive opened at $49.76 on Friday. The stock has a market capitalization of $2.59 billion, a P/E ratio of -66.35, a PEG ratio of 1.86 and a beta of 1.14. NuVasive has a fifty-two week low of $45.45 and a fifty-two week high of $66.17. The company’s fifty-day moving average price is $51.67 and its 200-day moving average price is $53.11. The company has a debt ratio of 1.09, a quick ratio of 1.88 and a current ratio of 3.18.

NuVasive (NASDAQ: NUVAGet a rating) last reported quarterly earnings data on Wednesday, May 4. The medical device company reported earnings per share (EPS) of $0.54 for the quarter, beating analyst consensus estimates of $0.38 by $0.16. The company posted revenue of $290.80 million for the quarter, compared to $277.63 million expected by analysts. NuVasive had a positive return on equity of 11.85% and a negative net margin of 3.23%. The company’s revenue for the quarter increased by 7.2% compared to the same quarter last year. In the same period last year, the company earned $0.37 per share. Equity research analysts expect NuVasive to post earnings per share of 2.31 for the current fiscal year.

Institutional entries and exits

Hedge funds have recently been buying and selling shares of the company. Polar Asset Management Partners Inc. purchased a new equity stake in NuVasive during Q1 valued at approximately $27,627,000. Nuance Investments LLC bought a new position in NuVasive in Q1 worth approximately $22,099,000. Woodline Partners LP bought a new position in NuVasive in Q4 worth approximately $14,490,000. Thrivent Financial for Lutherans increased its stake in NuVasive by 11.4% in Q4. Thrivent Financial for Lutherans now owns 2,147,399 shares of the medical device company worth $112,696,000 after acquiring an additional 219,982 shares last quarter. Finally, Nekton Capital Ltd. bought a new position in NuVasive in Q4 worth approximately $11,465,000.

About NuVasive

(Get a rating)

NuVasive, Inc., a medical technology company, develops, manufactures and sells procedural solutions for spine surgery. It provides surgical access instruments, including the Maxcess integrated split-blade retractor system that enables less invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by improving osseointegration and the biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and a fixation system that facilitates the preservation and restoration of patient alignment.

Recommended Stories

Stock Target Advisor logo

Analyst Recommendations for NuVasive (NASDAQ: NUVA)



Get news and reviews for NuVasive Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for NuVasive and related companies with MarketBeat.com’s free daily email newsletter.

]]>
Biden must act now to protect abortion rights – Herald Democrat https://regbiomed.com/biden-must-act-now-to-protect-abortion-rights-herald-democrat/ Fri, 15 Jul 2022 11:02:32 +0000 https://regbiomed.com/biden-must-act-now-to-protect-abortion-rights-herald-democrat/ New York Times Barely two weeks have passed since the Supreme Court overturned Roe v. Wade, and already chaos reigns. Several states are set to almost completely ban abortion, proponents of abortion rights are challenging these bans in court, and in some cases judges have been asked to issue injunctions that could, for a time, […]]]>

New York Times

Barely two weeks have passed since the Supreme Court overturned Roe v. Wade, and already chaos reigns. Several states are set to almost completely ban abortion, proponents of abortion rights are challenging these bans in court, and in some cases judges have been asked to issue injunctions that could, for a time, prevent the entry into force of the bans.

Doctors across the country, including in places where abortion is legal, are confused about what is and is not allowed, even when a patient’s life may be at stake. Patients are equally confused and panicked , and in some cases, their health is endangered.

President Biden, responding to harsh criticism from his own party that his administration has not done enough to uphold abortion rights, signed an executive order on Friday to help protect access to reproductive health care. In his remarks, Mr. Biden argued for Americans to elect a Congress that would vote to codify the rights once guaranteed by Roe v. Wade. He is right that it will be a long political fight to restore the constitutional right that the Supreme Court took away with its decision in Dobbs v. Jackson Women’s Health Organization.

At the same time, the Biden administration has an immediate duty to protect public health and the rights that Americans still have. The federal government can take several steps now, with laws already in effect, to strengthen abortion services in states where they are legal, support doctors facing legal and logistical dilemmas, and help women who may need cross state lines or secure abortion pills online. The executive order signed on Friday does little more than direct the secretary of health and human services to research ways to better enforce those existing laws and report back.

The need for action is clear, after years of research on how access to abortion affects women’s health. A recent study estimated that denying abortions in the United States would increase deaths of pregnant women by more than 20% overall, and more than 30% for black women – and that’s not counting deaths that may result from unsafe abortions. . While not all abortions will be denied in the new landscape, and how abortion pills are regulated could play an important role, the public health consequences of Roe’s reversal could be severe.

The most urgent action the federal government must take is to ensure access to medical abortion, the most common method of abortion, according to preliminary data from the Guttmacher Institute. In a strong public statement in support of abortion rights, Attorney General Merrick Garland underscored his commitment to “work with other branches of the federal government that seek to use their legitimate powers to protect and preserve access to care.” of procreation”. He noted, in particular, the Food and Drug Administration’s authority over abortive drugs. States cannot ban these drugs “based on disagreement with the expert judgment of the FDA,” he said.

The FDA should follow the Attorney General’s lead and say, unequivocally, that the agency’s approval and regulatory decisions regarding prescription drugs, including abortion pills, supersede any regulations or statutes at the US level. ‘State. This argument will almost certainly be challenged in court, but there is precedent to back it up. When Massachusetts tried in 2014 to ban Zohydro, an FDA-approved prescription pain reliever, the decision was overturned by a federal district court based on the FDA’s preventative powers.

The FDA’s pre-emptive authority should also be recognized by states that support abortion rights. At least 30 states, including some Democrats, have chosen to regulate abortion pills more tightly than the FDA does. Some require a doctor to dispense the pills, even though the FDA allows other qualified medical professionals to do so. Others require in-person appointments, even though the FDA allows telehealth consultations. The FDA should insist that these restrictions be removed and that the guidelines conform to federal guidelines.

The agency should also take immediate steps to ease restraints on medical abortion that experts have long deemed unnecessary. For example, the two-drug cocktail commonly used for medical abortion is approved for up to 10 weeks of pregnancy in the United States, but the World Health Organization has deemed it safe for up to 12 weeks. And as noted by The Atlantic, the pills were used safely even later.

Similarly, the FDA requires pharmacies to obtain certification to dispense either of the two pills, a policy that is not used in other countries and prevents access. To that end, federal officials should also support drugmaker GenBioPro in its Mississippi lawsuit challenging other restrictions; FDA public support would help, as would Justice Department involvement in the case.

The Centers for Medicare and Medicaid Services should also make clear, publicly, that all hospitals receiving federal Medicare and Medicaid funds (that is, almost all hospitals and clinics) are required to provide all drugs approved by the FDA and that emergency services are bound by the Medical Treatment and Labor Act, which requires medical professionals to provide necessary care in the event of a medical emergency.

Medicaid and health and human services should make it clear – again, unequivocally – that the emergency treatment law applies to abortion when a pregnancy is life threatening and they will apply it. (The Hyde Amendment, a legal provision that prohibits the use of federal funds for abortion, also contains a rape, incest, and medical emergency provision that still applies to government-funded health centers. federal.) Doctors faced with an ectopic pregnancy or miscarriage — which can be life-threatening if fetal tissue stays in the body too long — might be less afraid to act if they were reminded that inaction is still a crime and if they knew the federal government would support them.

Other federal agencies also have a role to play. The Centers for Disease Control and Prevention can aggressively monitor and publicize illnesses and deaths in states where abortion is no longer available. As America’s premier public health agency, the CDC has an obligation not only to continue to study the harm to public health caused by limits on access to abortion, but also to speak publicly about its intention to do so. TO DO. The Federal Trade Commission can specify that anyone who tries to sell fake abortion drugs, online or elsewhere, will be prosecuted.

It is true, as administration officials have said, that there are no easy solutions to the fight for abortion rights in which Americans are currently engaged; even among those who favor reproductive rights, there is little consensus on the best solution. It is also true that any action taken by the administration can lead to litigation. But given the serious threat to public health, not acting is not an option.

]]>
Identification and management of acute kidney injury https://regbiomed.com/identification-and-management-of-acute-kidney-injury/ Mon, 11 Jul 2022 07:55:37 +0000 https://regbiomed.com/identification-and-management-of-acute-kidney-injury/ Christopher Stephen Claire Charge Nurse, Intensive Care Unit, Southmead Hospital, Bristol, England Why you should read this article: • Improve your knowledge of the pathophysiology, staging, and signs and symptoms of acute kidney injury • To familiarize yourself with treatments for acute kidney injury, such as fluid management and renal replacement therapy • […]]]>

Christopher Stephen Claire Charge Nurse, Intensive Care Unit, Southmead Hospital, Bristol, England



Why you should read this article:

  • Improve your knowledge of the pathophysiology, staging, and signs and symptoms of acute kidney injury

  • To familiarize yourself with treatments for acute kidney injury, such as fluid management and renal replacement therapy

  • To count towards revalidation as part of your 35 hours of CPD, or you may wish to write a reflective report (UK readers)

  • To help with your professional development and local registration renewal requirements (non-UK readers)

Acute renal failure, formerly known as acute renal failure, is a common and often preventable condition seen in patients in acute and primary care settings. Nurses in both settings should be able to identify and assess patients at risk for acute kidney injury and those who develop acute kidney injury, and understand the principles of clinical management. Early identification can help prevent acute kidney injury, while management and supportive interventions can prevent further deterioration in patients diagnosed with the disease. This article describes acute kidney injury and describes the pathophysiology, staging, signs, and symptoms. The author also describes the clinical management of patients with acute renal failure and the long-term effects of the disease.

Nursing standard.
do I: 10.7748/ns.2022.e11938

Peer review

This article has undergone external double-blind peer review and plagiarism check using automated software

Correspondence

ChrisSClare@googlemail.com

Conflict of interest

None declared

Clare CS (2022) Identification and management of acute kidney injury. Nursing standard. doi:10.7748/ns.2022.e11938

Online: July 11, 2022

You want to know more ?

Already registered? Login

WHERE

Unlock Full Access to RCNi Plus Today

Save over 50% on your first 3 months

Your subscription package includes:

  • Unlimited online access to the 10 RCNi journals and their archives
  • Customizable dashboard with over 200 topics
  • RCNi Learning with over 180 RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalized newsletters tailored to your interests

Subscribe

RCN student member? Try Standard Nursing Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or

]]>
The Toronto Center for Functional Medicine explains the functional medicine perspective on thyroid toxicity https://regbiomed.com/the-toronto-center-for-functional-medicine-explains-the-functional-medicine-perspective-on-thyroid-toxicity/ Sat, 09 Jul 2022 15:25:32 +0000 https://regbiomed.com/the-toronto-center-for-functional-medicine-explains-the-functional-medicine-perspective-on-thyroid-toxicity/ Toronto, ON – Toronto Functional Medicine Center in Toronto, ON, Canada, recently posted a blog post that offers the functional medicine perspective on thyroid toxicity. Toxins can take the form of bacteria, excessive doses of certain prescription medications, and even chemicals and heavy metals, such as lead and cadmium. These toxins can trigger acute or […]]]>

Toronto, ON –

Toronto Functional Medicine Center in Toronto, ON, Canada, recently posted a blog post that offers the functional medicine perspective on thyroid toxicity. Toxins can take the form of bacteria, excessive doses of certain prescription medications, and even chemicals and heavy metals, such as lead and cadmium. These toxins can trigger acute or chronic health issues, especially poor thyroid health. The thyroid has the important function of releasing hormones for fertility, metabolism, and various bodily systems.

The problem is that exposure to toxins is a common occurrence. Indeed, people in developed countries spend more than 90% of their time indoors and indoor environments contribute significantly to human environmental exposures. Sometimes there is also acute and chronic exposure to toxins in the workplace, for example due to mold and improper handling of chemicals. And the toxins can also be found in common products, such as plastic bottles, which may contain bisphenol A (BPA), couch flame retardants, fruit and vegetable pesticides, second-hand cigarette smoke and cosmetics. .

Eliminating toxins is necessary at all ages because, for one thing, exposure to toxins can affect thyroid health. Toxins can interrupt the functions of thyroid hormones and interfere with the metabolism of T3 and T4, which are the hormones produced by the thyroid. Some toxins even bear a structural resemblance to T3 and T4 and prevent thyroid hormones from binding to cell receptors or transferring proteins, leading to thyroid problems. Additionally, heavy metals can cause antibodies to attack the thyroid, which can lead to autoimmune disease that prevents the thyroid from working properly, such as Hashimoto’s thyroiditis and Graves’ disease.

Fortunately, integrative functional medicine approaches can aid in the elimination and prevention of toxins. At the Center for Functional Medicine in Toronto, certain laboratory tests were first suggested to check the current state of the thyroid. Their functional medicine practitioners can then develop a comprehensive treatment plan using a wide range of treatment modalities. For example, they may recommend dietary supplements, chelation therapy, and/or a metabolic reset detox program.

Using an evidence-based approach, they can recommend oral and intravenous iodine supplementation, which can help manage hypothyroidism. Iodine can promote the production of the T3 and T4 hormones. In chelation therapy, the patient ingests a chelating agent or IV therapy can be used to introduce the chelating agent into the bloodstream to help detoxify the body of heavy metals. And in the Metabolic Reset Detox Program, a personalized detox plan is developed that can help revitalize the metabolism, while promoting weight loss and healthy detox.

At the Toronto Functional Medicine Center they investigate the root causes of the patient’s health issues. Their integrative care encompasses functional care and collaboration, and they encourage patients and health care providers to develop treatment plans together.

Toronto Center for Functional Medicine uses an integrative functional medicine approach, where they integrate functional medicine methods with restorative medicine, including Traditional Chinese Medicine (TCM) or Oriental Medicine, Naturopathic Medicine, Allopathic Medicine, bio-identical hormone replacement, herbal medicine, and more. They use integrative functional medicine therapies for various types of health conditions, such as: chronic diseases, hormonal imbalances, neuropathic pain, acute health conditions, post-menopausal health conditions, etc. Health issues they may be able to help include: chronic fatigue, tissue repair, cell damage, DNA repair, athletic recovery, mineral deficiencies, thyroid issues, infertility, immune function, skin rejuvenation, adrenal function and others. This private Toronto clinic takes a patient-centered approach to wellness and its functional medicine programs can be used for acute and chronic care.

Those wishing to learn more about the treatment services provided, such as the removal of toxins to help improve thyroid health in Toronto and also how to use functional medicine to fight candidacan visit the Toronto Functional Medicine Center website or contact them at Telephone (416) 968-6961or by email to [email protected].

###

For more information about the Toronto Center for Functional Medicine, contact the company here:

Toronto Functional Medicine Center
(416) 968-6961
[email protected]
Toronto Functional Medicine Center
162 Cumberland Street 222A
Toronto, ON M5R 1A8

]]>